Prognostic Significance of DNA Repair Gene mRNA Expression in Early-Stage Breast Cancer: Insights into Clinical Relevance

Read full text
Authors: Ina Shehaj, Slavomir Krajnak, Katrin Almstedt, Yaman Degirmenci, Roxana Michaela Schwab, Kathrin Stewen, Walburgis Brenner, Annette Hasenburg, Marcus Schmidt, Anne-Sophie Heimes
Cited by: 0

Abstract

and patient prognosis. High mRNA expression of ATM was associated with longer metastasis-free survival (MFS). Conversely, lower mRNA expression of BLM correlated with favorable outcomes, particularly in triple-negative tumors. Additionally, high levels of WRN mRNA expression were linked to significantly longer MFS compared to low expression levels. This study highlights the prognostic significance of ATM, BLM, and WRN in predicting survival outcomes in eBC patients. Background: The prognostic significance of various biological and non-BRCA genetic in early-stage breast cancer (eBC) remains unclear and warrants further investigation. This study therefore aimed to evaluate the prognostic impact of these genes on clinical outcomes in breast cancer. Methods: Patients included in this study were subdivided into two groups based on low and high messenger ribonucleic acid (mRNA) expression levels. Statistical analysis, including Kaplan-Meier curves, univariable, and multivariable Cox regression analyses, was performed to assess metastasis-free survival (MFS) of mRNA expression of non-BRCA genes. Subgroup analyses were also conducted among four different molecular subtypes of eBC. Results: = 0.009, Log Rank). Conclusions: , for survival outcomes in eBC.

Fields of Study & Subjects

Breast Cancer Treatment Studies BRCA gene mutations in cancer DNA Repair Mechanisms

Publication details

Journal / source
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Volume
34
Issue
3
Pages
1–10
Publication date
1 January 2026
Language
EN